A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis
Clinical trial NCT05730725 · COMPLETED
Trial details
- NCT number
- NCT05730725
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-03
- Primary completion
- 2024-08-06
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.